Should next-generation sequencing testing be routinely used in metastatic colorectal cancer? - PubMed - NCBI

Should next-generation sequencing testing be routinely used in metastatic colorectal cancer? - PubMed - NCBI

Lancet Oncol. 2018 Nov;19(11):1434-1435. doi: 10.1016/S1470-2045(18)30776-9. Epub 2018 Nov 1.

Should next-generation sequencing testing be routinely used in metastatic colorectal cancer?

Dienstmann R, Ciner A, Hochster HS.

PMID:

 

30507475

 

DOI:

 

10.1016/S1470-2045(18)30776-9